This investigator-initiated , prospective , multicentre , randomised , controlled clinical trial enrolled patients with stable GOLD stage IV COPD and a partial carbon dioxide pressure ( PaCO@ ) of @ kPa ( @ mm Hg ) or higher and pH higher than @ .